|
CASP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.005500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.158440E-03 |
| Normal-vs-Stage2 |
2.956100E-03 |
| Normal-vs-Stage3 |
1.278760E-03 |
| Normal-vs-Stage4 |
1.029910E-04 |
| Stage1-vs-Stage2 |
6.778600E-01 |
| Stage1-vs-Stage3 |
4.769800E-01 |
| Stage1-vs-Stage4 |
1.693640E-01 |
| Stage2-vs-Stage3 |
9.088800E-01 |
| Stage2-vs-Stage4 |
4.096000E-01 |
| Stage3-vs-Stage4 |
4.406400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.063870E-03 |
| Normal-vs-AfricanAmerican |
4.222000E-02 |
| Normal-vs-Asian |
3.209700E-02 |
| Caucasian-vs-AfricanAmerican |
9.968200E-01 |
| Caucasian-vs-Asian |
3.758400E-01 |
| AfricanAmerican-vs-Asian |
6.095200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.121600E-03 |
| Normal-vs-Female |
1.759000E-04 |
| Male-vs-Female |
8.718200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.962900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.808140E-04 |
| Normal-vs-Age(61-80Yrs) |
2.161400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.749900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.346200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.928200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.481400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.240800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.075600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.561200E-01 |
| Classical-VS-Follicular |
1.417400E-04 |
| Classical-VS-Other |
5.369200E-01 |
| Classical-VS-Normal |
6.180600E-03 |
| Tall-VS-Follicular |
1.097800E-01 |
| Tall-VS-Other |
8.058800E-01 |
| Tall-VS-Normal |
3.116200E-02 |
| Follicular-VS-Other |
5.416600E-01 |
| Follicular-VS-Normal |
1.29999999998187E-06 |
| Other-VS-Normal |
1.192610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.404060E-04 |
| Normal-vs-N1 |
2.801000E-04 |
| N0-vs-N1 |
3.861400E-01 |
|
|
